iSpecimen Inc
NASDAQ:ISPC
iSpecimen Inc
Cash from Financing Activities
iSpecimen Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
iSpecimen Inc
NASDAQ:ISPC
|
Cash from Financing Activities
$70.9k
|
CAGR 3-Years
-67%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
NYSE:VEEV
|
Cash from Financing Activities
-$16.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Cash from Financing Activities
$14m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Evolent Health Inc
NYSE:EVH
|
Cash from Financing Activities
$281.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Doximity Inc
NYSE:DOCS
|
Cash from Financing Activities
-$74.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Certara Inc
NASDAQ:CERT
|
Cash from Financing Activities
-$9.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is iSpecimen Inc's Cash from Financing Activities?
Cash from Financing Activities
70.9k
USD
Based on the financial report for Dec 31, 2023, iSpecimen Inc's Cash from Financing Activities amounts to 70.9k USD.
What is iSpecimen Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-54%
The average annual Cash from Financing Activities growth rates for iSpecimen Inc have been -67% over the past three years , -54% over the past five years .